Andersson P, Dubiel W, Enghoff E, Friman G, Hägg A, Nyström S O, Aberg T
Acta Med Scand. 1986;219(3):275-82. doi: 10.1111/j.0954-6820.1986.tb03311.x.
One-hundred-and-thirteen patients with endocarditis and valvular insufficiency were studied retrospectively with special regard to indications for operation and the optimum time for cardiac valve surgery. Thirty patients (group I) had acute, 63 (group II) subacute and 20 (group III) prosthetic valve endocarditis. Group I: Eleven patients underwent surgery in the acute stage, 8 while bacteremic; 5 of the latter died perioperatively. Of the 19 patients treated medically, 16 died. Group II: All patients underwent operation in a bacteria-free state. The mortality was 5%. Group III: Eight patients had early (less than 60 days postoperatively) and 12 late endocarditis. Total mortality was 40% (71% early and 25% late mortality). Ten patients underwent reoperation, with a mortality of 20%, compared with 60% in the medically treated group. The results support the indication for early operation in acute endocarditis with progressive cardiac failure and renal failure and prosthetic valve endocarditis, even during bacteremia.
对113例患有心内膜炎和瓣膜关闭不全的患者进行了回顾性研究,特别关注手术指征和心脏瓣膜手术的最佳时机。30例患者(I组)患有急性心内膜炎,63例(II组)患有亚急性心内膜炎,20例(III组)患有人工瓣膜心内膜炎。I组:11例患者在急性期接受了手术,其中8例在菌血症期间手术;后者中有5例在围手术期死亡。在接受药物治疗的19例患者中,16例死亡。II组:所有患者均在无菌状态下接受手术。死亡率为5%。III组:8例患者患有早期(术后不到60天)心内膜炎,12例患有晚期心内膜炎。总死亡率为40%(早期死亡率为71%,晚期死亡率为25%)。10例患者接受了再次手术,死亡率为20%,而药物治疗组的死亡率为60%。这些结果支持在急性心内膜炎合并进行性心力衰竭和肾衰竭以及人工瓣膜心内膜炎时尽早手术的指征,即使在菌血症期间也是如此。